Metraipolis › archive › dc_676ae0ed6922

Efficacy and safety of AAV-mediated gene therapy for choroideremia: a systematic review and meta-analysis — Europe PMC PMID:42180403

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180403
DOI
10.1016/j.eclinm.2026.103923
License (as archived)
solo-consultazione
Archived
2026-11-02T12:11:56.876Z
SHA-256 of the archived text
0d516c13e4c541cbd2c0e92caf95871f4723a21fee9c83dccf2e8ac82d5e780d
Stable URL of this page
https://metraipolis.com/documento/dc_676ae0ed6922

How to cite

Efficacy and safety of AAV-mediated gene therapy for choroideremia: a systematic review and meta-analysis — Europe PMC PMID:42180403 — Europe PMC (en), https://europepmc.org/article/MED/42180403 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_676ae0ed6922 (Metraipolis archive dc_676ae0ed6922, sha256 0d516c13e4c541cbd2c0e92caf95871f4723a21fee9c83dccf2e8ac82d5e780d)
BibTeX
@misc{dc676ae0ed6922,
  title = {Efficacy and safety of AAV-mediated gene therapy for choroideremia: a systematic review and meta-analysis — Europe PMC PMID:42180403},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180403},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_676ae0ed6922; sha256 0d516c13e4c541cbd2c0e92caf95871f4723a21fee9c83dccf2e8ac82d5e780d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180403. Agents can read the archived copy with the MCP tool read_document.